Physician profile
Rotesha Colbert
NPI 1932591799
$689.59
in general payments reported to CMS, 2019-2025
20 companies · $140 in 2025
The $140 reported for 2025 was more than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $192 · 2022: $26.34 · 2023: $180 · 2024: $151 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $471.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $471.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $161.13 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Merck Sharp & Dohme LLC | $53.31 | 2021-2025 | Gardasil 9, Capvaxive, Vaxneuvance |
| Amgen INC. | $52.18 | 2021-2024 | Repatha, Otezla |
| Abbvie INC. | $43.70 | 2023-2025 | |
| Abbott Laboratories | $37.70 | 2023 | Freestyle Libre 3 |
| Amarin Pharma, INC. | $37.70 | 2021 | |
| Sunovion Pharmaceuticals INC. | $36.06 | 2021 | |
| Pfizer INC. | $29.28 | 2021-2025 | |
| Corium, LLC | $26.34 | 2024 | Azstarys |
| Viatris Specialty LLC | $25.42 | 2025 | Yupelri |
| Impulse Dynamics (USA) INC. | $22.83 | 2023 | Optimizer |
| Daiichi Sankyo INC. | $22.69 | 2024 | Injectafer |
| Sanofi Pasteur INC. | $22.62 | 2023 | |
| Seqirus USA INC | $22.13 | 2024 | Flucelvax, Fluad |
| Exact Sciences Corporation | $20.77 | 2024 | Cologuard Collection Kit |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $17.63 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Dexcom, INC. | $15.38 | 2021 | |
| Cranial Technologies, INC | $14.62 | 2021 | |
| Glaxosmithkline, LLC. | $14.14 | 2023 | Shingrix, Arexvy |
| Inspire Medical Systems, INC. | $13.96 | 2023 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rotesha Colbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.